VIAVI Solutions
VIAV
$30.30
-14.38%
Viavi Solutions is a global test-and-measurement and optical technology company whose Network and Service Enablement (NSE) segment supplies instruments, software, and assurance platforms used by telecom operators, data-center operators, and network-equipment vendors, while its Optical Security and Performance Products (OSP) segment makes optical coatings for anti-counterfeiting, consumer electronics, aerospace, and automotive applications. Viavi is best characterized as a niche, high-value enabler of critical infrastructure rather than a broad platform vendor — its test gear and resilient Position, Navigation and Timing (PNT) solutions sit inside networks, data centers, and defense/aerospace systems where reliability and precision matter more than scale, and roughly 89% of segment revenue comes from product sales versus services. The investor narrative has shifted decisively toward AI-driven optical and data-center demand, amplified by the Spirent acquisition that materially expanded the company's test portfolio and revenue base, with fiscal Q4 2026 revenue up 52.5% year over year and management commentary pointing to continued AI infrastructure tailwinds. That bullish fundamental story is now colliding with a sharp post-earnings share-price drawdown and questions about Spirent integration risk, elevated leverage, and whether the growth is durable enough to justify a premium multiple.…
VIAV
VIAVI Solutions
$30.30
Related headlines
VIAV 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on VIAVI Solutions's 12-month outlook, with a consensus price target around $61.43 and implied upside of +102.7% versus the current price.
Average Target
$61.43
0 analysts
Implied Upside
+102.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$44 - $70
Analyst target range
Seven analysts cover Viavi with a consensus recommendation of "strong_buy" (mean rating of 1.375 on a 1-5 scale where 1 is a strong buy), and the average target price of $61.43 implies roughly +84% upside from the current $33.38 — an unusually large gap that signals the selloff has run well ahead of published fundamental views. The consensus is unambiguously bullish, with recent actions showing Rosenblatt reiterating Buy on 2026-09-23 and 2026-08-19, B. Riley, Stifel, and Needham all at Buy on 2026-08-06, and only UBS maintaining a Neutral stance; there have been no downgrades in the visible ratings history, which suggests analysts are treating the decline as a dislocation rather than a thesis break. The target range of $44.00 to $70.00 is wide — a $26 spread, or roughly 42% of the midpoint — which signals high uncertainty about the growth trajectory and integration outcome. The high target of $70.00 likely assumes sustained AI-driven optical demand, successful Spirent integration, and multiple expansion back toward the stock's 2026 highs, while the low target of $44.00 (still +32% above the current price) appears to price in margin compression and a more modest earnings recovery rather than a bear-case collapse. Notably, even the lowest published target sits well above the current price, which is a strong signal that the market's recent -9.34% single-day drop and -41.75% max drawdown have overshot fundamental expectations — though the wide dispersion and the stock's 1.21 beta mean investors should expect continued volatility and treat the consensus as a directional signal rather than a precise price forecast.
Bulls vs Bears: VIAV Investment Factors
The evidence is genuinely two-sided, but the bear case currently has the stronger near-term grip: the stock is in an accelerating downtrend (-9.34% single day, -24.4% six months, -15.2 relative-strength points versus SPY over three months) even as fundamentals improved dramatically. The bull case rests on hard numbers — 52.5% revenue growth, 62.5% gross margin, a 17.1x forward PE, and an $61.43 average analyst target implying ~84% upside — while the bear case rests on execution and durability: negative trailing margins, 63.8x EV/EBITDA, and unproven Spirent integration. The single most important tension is whether the Q4 revenue step-change is a durable AI-infrastructure run-rate or a pull-forward; if the next quarter confirms $440 million-plus with expanding margins, the valuation looks cheap, but if revenue normalizes toward $350 million, the 7.2x PS and 2.02 PEG become hard to defend. Until that is resolved, the market is pricing a binary outcome and momentum favors caution over conviction.
Bullish
- Revenue accelerating at 52.5% YoY: Fiscal Q4 2026 revenue hit $443.1 million, up 52.5% year over year, and rose 48% sequentially from $299.1 million in Q1 2026. This is a genuine step-change in the top line, not a modest reacceleration, and it is the single strongest data point in the bull case.
- Analyst targets imply ~84% upside: Seven analysts carry a consensus 'strong_buy' (mean 1.375) with an average target of $61.43 versus the $33.38 close, roughly +84% upside. Even the lowest published target of $44.00 sits ~32% above the current price, suggesting the selloff has overshot published fundamental views.
- Gross margin recovering to 62.5%: Q4 2026 gross margin of 62.5% is up from 55.7% in Q3 and 55.3% in Q2, and gross profit of $276.9 million on $443.1 million of revenue shows pricing power and mix improvement. The trailing gross margin of 57.7% is respectable for a hardware-led test vendor.
- Forward PE of 17.1x is not stretched: With consensus FY EPS of $2.51, the forward PE of 17.1x is reasonable for a company growing revenue 52.5%, especially versus the unusable trailing PE of -366x. The PS of 7.2x also sits in the lower-middle of its own 6.1x–24.7x historical band.
Bearish
- Momentum has decisively broken down: The stock fell -9.34% in a single session and is -24.4% over six months and -12.5% over three months, with relative strength of -15.2 points versus SPY over three months. At $33.38 it sits ~57% below its $60.43 52-week high and has surrendered most of its 2026 gains despite a still-positive +83.9% YTD.
- Profitability is thin and erratic: Trailing net margin is -2.0% with EPS of -$0.0028, and the last four quarters swung from -$21.4 million (Q1) and -$48.1 million (Q2) to $6.4 million (Q3) and $32.7 million (Q4). Operating margin of just 6.9% and ROE of -2.1% show the revenue surge is not yet converting into consistent earnings.
- Extreme EV/EBITDA and cash-flow multiples: EV/EBITDA of 63.8x and price-to-cash-flow of 96.0x reflect a depressed EBITDA base ($57 million in Q4) rather than durable cash generation. The PEG of 2.02 signals the market is already paying up for growth that is well understood.
- Spirent integration and leverage risk: Interest expense of $13.7 million in Q4 alone and a cash-flow-to-debt ratio of 0.095 with 0.80 interest coverage highlight that leverage still constrains flexibility. The 52.5% growth is partly acquisition-driven, so durability of the new run-rate is unproven.
VIAV Technical Analysis
The prevailing trend is best described as a violent recovery that has rolled over into a sharp correction: despite a 1-year gain of +150.6% (versus +15.5% for SPY, a relative-strength spread of +135.1 points), the stock closed at $33.38 on 2026-10-16, only about 43% of the way up its 52-week range of $12.77 to $60.43. That positioning — roughly 57% below the 52-week high but still 161% above the low — means the stock is neither a clean momentum leader nor a value opportunity; it is a high-beta name that has surrendered most of its 2026 gains, with the YTD return still positive at +83.9% but the 6-month change at -24.4%. The 52-week high of $60.43 was set earlier in the year, and the current price sits far enough below it that the prior uptrend structure is broken on any intermediate timeframe. Recent momentum is decisively negative and accelerating: the stock fell -9.34% on the final session alone, is down -3.16% over one month and -12.53% over three months, with relative strength of -4.38 points versus SPY over one month and -15.22 points over three months. This is a clear divergence from the +150.6% one-year trend and signals that the market is repricing the growth story rather than merely consolidating — the 1-month weakness is compounding the 3-month weakness rather than mean-reverting, and the -41.75% max drawdown confirms a pattern of sharp, high-velocity selloffs. Key levels are the 52-week low of $12.77 as the ultimate support zone and the 52-week high of $60.43 as major resistance, with the recent swing low near $32.23 (July 2026) now the immediate line in the sand; a break below that would open the door toward the $20s, while reclaiming the $44-48 area would be the first sign of stabilization. With a beta of 1.213, the stock is roughly 21% more volatile than the market, and the -9.34% single-day move underscores that position sizing must account for gap risk; the short ratio of 2.43 is moderate and does not suggest a crowded short base that would fuel a violent squeeze.
Beta
1.21
1.21x market volatility
Max Drawdown
-45.2%
Largest decline past year
52-Week Range
$13-$60
Price range past year
Annual Return
+129.0%
Cumulative gain past year
| Period | VIAV Return | S&P 500 |
|---|---|---|
| 1m | -16.8% | -1.2% |
| 3m | -23.3% | +3.4% |
| 6m | -36.5% | +7.0% |
| 1y | +129.0% | +14.4% |
| ytd | +66.9% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
VIAV Fundamental Analysis
Revenue is growing at an exceptional pace: fiscal Q4 2026 (quarter ended 2026-06-27) revenue was $443.1 million, up 52.5% year over year, following $406.8 million in Q3 2026, $369.3 million in Q2 2026, and $299.1 million in Q1 2026 — a clear sequential acceleration that reflects both organic AI/optical demand and the Spirent acquisition contribution. The multi-quarter trend is unambiguous: quarterly revenue rose from $299.1 million to $443.1 million over three quarters, a 48% sequential increase, and product revenue of $392.9 million dwarfs service revenue of $50.2 million, meaning the growth is hardware-led and therefore more cyclical and lumpier than a recurring software model. The investment case hinges on whether this step-change is a durable new run-rate tied to AI data-center buildouts or a pull-forward that normalizes, and the recent share-price collapse suggests the market is increasingly skeptical of the latter. Profitability is improving but remains thin and uneven: Q4 2026 net income was $32.7 million (7.4% net margin) on a 62.5% gross margin, a sharp rebound from the Q2 2026 loss of -$48.1 million (-13.0% net margin) and Q1 2026 loss of -$21.4 million, while Q3 2026 net income was only $6.4 million (1.6% margin). Gross margin has been volatile — 62.5% in Q4 2026 versus 55.7% in Q3 2026 and 55.3% in Q2 2026 — and the trailing net margin of -2.0% with an operating margin of just 6.9% shows that the company is not yet converting its revenue surge into consistent bottom-line profitability, with interest expense of $13.7 million in Q4 alone a meaningful drag. Balance-sheet health is adequate but not fortress-like: debt-to-equity is 0.48, the current ratio is 1.85, and cash stood at $659.8 million at Q4 2026 after the company repaid $450 million of debt and issued $575 million of common stock during the quarter. Free cash flow is lumpy — $55.6 million in Q4 2026 and $82.8 million TTM, but -$32.2 million in Q3 2026 — and with ROE at -2.1% and ROA at 4.6%, the company is not yet generating returns that comfortably cover its cost of capital; the cash flow to debt ratio of 0.095 and interest coverage of 0.80 in the Q4 historical ratios highlight that leverage remains a real constraint on financial flexibility.
Quarterly Revenue
$443100000.0B
2026-06
Revenue YoY Growth
+52.5%
YoY Comparison
Gross Margin
62.5%
Latest Quarter
Free Cash Flow
$82800000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is VIAV Overvalued?
Because trailing net income is negative (EPS of -$0.0028 and a trailing PE of -366.4x), the PE ratio is not a meaningful primary metric; I therefore lead with the forward PE of 17.1x, which is the cleanest read on the market's earnings-based valuation given consensus FY EPS estimates of $2.51. The gap between the unusable trailing PE and the 17.1x forward multiple implies the market expects a dramatic earnings inflection — essentially pricing in the full realization of the AI/Spirent growth story — while the PS ratio of 7.2x and EV/Sales of 6.0x provide the revenue-based cross-check. On a peer basis, a 7.2x PS and 6.0x EV/Sales are rich for a communication-equipment test-and-measurement vendor, where mid-single-digit sales multiples are more typical; the premium is justified only if the 52.5% revenue growth rate and 62.5% gross margin prove sustainable, and the 17.1x forward PE versus a PEG of 2.02 suggests the market is paying up for growth that is already well understood. The EV/EBITDA of 63.8x and price-to-cash-flow of 96.0x are extreme and reflect a depressed EBITDA base ($57 million in Q4 2026) rather than a durable cash-generation multiple, which is a caution flag. Historically, Viavi's PS ratio has ranged from roughly 6.1x (Q4 2024) to 24.7x (Q4 2026) and its PE has swung from negative to 79x, so the current 7.2x PS sits in the lower-middle of its own multi-year band — closer to the 2024 trough than the 2026 peak — which suggests the recent selloff has already compressed the multiple meaningfully. That said, the historical band is so wide and earnings so volatile that the multiple offers limited anchoring; the stock is neither obviously cheap nor obviously expensive on its own history, and the market is effectively pricing a binary outcome on growth durability.
PE
-366.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 23x~79x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
63.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on thin, volatile profitability and acquisition-driven leverage. Trailing net margin is -2.0% with EPS of -$0.0028, and quarterly net income swung from -$48.1 million in Q2 2026 to +$32.7 million in Q4, showing earnings are not yet stable. Interest expense of $13.7 million in Q4 and interest coverage of 0.80 mean debt service consumes a large share of operating income ($11.0 million in Q4), while the cash-flow-to-debt ratio of 0.095 leaves limited cushion. Revenue is also concentrated in hardware (product revenue of $392.9 million versus $50.2 million of services), making results sensitive to lumpy AI data-center capex and Spirent integration execution.
Market and competitive risks are dominated by valuation compression and high beta. At 7.2x PS, 6.0x EV/Sales, 63.8x EV/EBITDA, and 96.0x price-to-cash-flow, the stock trades at a premium that assumes sustained 50%+ growth; any deceleration would compress multiples sharply. The beta of 1.213 means the stock amplifies market moves by roughly 21%, and the -9.34% single-day drop confirms gap risk. Competitive pressure is visible in the news flow — Ciena's AI-led optical demand and 37% YoY growth (September 2026) and Onto Innovation's AI-chip positioning (October 2026) show rivals competing for the same AI infrastructure dollars, while supply constraints across optical networking could cap upside.
Worst-case scenario: a Q1 FY2027 revenue print that normalizes toward $350 million, combined with Spirent integration charges and margin compression back toward the 55% level, would trigger analyst downgrades and a multiple reset toward the low end of the historical PS band (~6.1x). That would put the stock on a path toward the $20s, with the July 2026 swing low of $32.23 as the first break point and the $12.77 52-week low as the extreme floor. From the current $33.38, a retest of the 52-week low would represent roughly -62%, while a more realistic bear-case target near the $44 analyst low is actually above the current price — meaning the immediate downside is better framed as a break below $32.23 opening a path to the mid-$20s, or roughly -25% to -30% from here.